July 15, 2026 a 07:43 am

RVTY: Fundamental Ratio Analysis - Revvity, Inc.

Revvity, Inc. Stock Overview

Revvity, Inc., formerly known as PerkinElmer, Inc., operates in the healthcare sector. With a focus on diagnostics and life sciences, the company offers innovative solutions. Revvity's dedication to scientific breakthroughs positions it well for future growth. However, competitive pressures in its sectors remain a concern.

Fundamental Rating

Revvity, Inc. demonstrates solid fundamental ratings, highlighting strengths in some financial metrics.

Category Score Visualization
Discounted Cash Flow 4
Return on Equity 3
Return on Assets 3
Debt to Equity 2
Price to Earnings 1
Price to Book 4

Historical Rating

Examining scores over time provides insights into the company's financial trajectory.

Date Overall DCF ROE ROA D/E P/E P/B
Current: 3 4 3 3 2 1 4
2026-07-14 3 4 3 3 2 1 4

Analyst Price Targets

Analyst predictions reflect varying perspectives on the stock's potential trajectory.

High Low Median Consensus
125 95 115 111.57
Stock Price Chart of Revvity, Inc.

Analyst Sentiment

Analysts maintain a positive outlook, with a strong presence of 'Buy' recommendations.

Recommendation Count Visualization
Strong Buy 0
Buy 15
Hold 14
Sell 0
Strong Sell 0

Conclusion

Revvity, Inc. (RVTY) presents a balanced investment opportunity with robust scores in discounted cash flow and price-to-book ratios. The firm's revised outlook under its new brand name and strategy in diagnostics and life sciences portrays potential growth, although investor caution is advised due to market competition. Analysts largely view the stock favorably, suggesting optimism in its future performance, though acknowledging risks. Investors should consider both the opportunities for scientific advancement and the inherent challenges in the sector.

Smart Data Insight

Master the Perfect Entry & Exit for this Stock

Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.

  • ✅ Identify the "Golden Buying Window"
  • ✅ Avoid high-risk correction cycles
  • ✅ Backtested data from the last 20+ years

Ready to trade with an edge?

Analyze Patterns Now →

Limited Free Lookups Available Today